Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience
Human Gene Therapy · 2023
DOI: 10.1089/hum.2022.232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2023. Verfasst von Richa Madan Lomash und 6 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutic Development Branch, Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), NIH, Rockville, Mar…. Hauptthemen laut MEDLINE: Orphan Drug Production, Propionic Acidemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Therapeutic Development Branch, Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), NIH, Rockville, Maryland, USA.
- Organic Acid Research Section, Molecular Medicine Branch, National Human Genome Research Institute (NHGRI), NIH, Bethesda, Maryland, USA.
- Division of Rare Diseases Research Innovation, NCATS, NIH, Rockville, Maryland, USA.
ORCID-Profile: Richa Madan Lomash, Charles P Venditti
Förderung
- Intramural NIH HHS
Zitieren
APA
Lomash, R. M., Shchelochkov, O., Chandler, R. J., Venditti, C. P., Pariser, A. R., Ottinger, E. A., & NIH PaVe-GT Team (2023). Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience. Human Gene Therapy. https://doi.org/10.1089/hum.2022.232
Vancouver
Lomash RM, Shchelochkov O, Chandler RJ, Venditti CP, Pariser AR, Ottinger EA, et al. Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience. Human Gene Therapy. 2023. doi:10.1089/hum.2022.232
BibTeX
@article{Lomash2023,
author = {Lomash, Richa Madan and Shchelochkov, Oleg and Chandler, Randy J and Venditti, Charles P and Pariser, Anne R and Ottinger, Elizabeth A and NIH PaVe-GT Team, NIH PaVe-GT Team},
title = {Successfully Navigating Food and Drug Administration Orphan Drug and Rare Pediatric Disease Designations for AAV9-hPCCA Gene Therapy: The National Institutes of Health Platform Vector Gene Therapy Experience},
journal = {Human Gene Therapy},
year = {2023},
doi = {10.1089/hum.2022.232}
}
EUVIMED